Jul 22, 09:09
Jul 22, 09:07
AnnouncementsAjanta Pharma declares dividend payment date
AnnouncementsAjanta Pharma: Fixes Book Closure for Dividend & AGM
60% of moneycontrol users recommend buying Ajanta Pharma.
What's your call on Ajanta Pharma today?
Read 4 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2690.45||1.29||2939.80||2140.35||45,827.79|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|Scheme||No. of Shares|
|Franklin India Prima Fund (G)||52,290|
|SBI Pharma Fund (G)||44,718|
|Motilal Oswal MOSt Focused Multicap 35 Fund - Direct Plan (G)||22,650|
|Motilal Oswal MOSt Focused Multicap 35 Fund - Regular Plan (G)||20,553|
Jindal PolyFilms Recommended on May 27th 2014
Recommended price 177.00 | Peak from reco 278.40 57.29%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Ajanta Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 5,399.15 crore.The company has reported a standalone sales of Rs 301.14 crore and a Net Profit of Rs 70.09 crore for the quarter ended Mar 2014.
The company management includes Rajesh M Agrawal - Joint Managing Director, K H Viswanathan - Additional Director, Mannalal B Agrawal - Chairman, Purushottam B Agrawal - Vice Chairman, Madhusudan B Agrawal - Vice Chairman, Yogesh M Agrawal - Managing Director, Anil Kumar - Director, Chandrakant M Khetan - Director.
It is listed on the BSE with a BSE Code of 532331 and the NSE with an NSE Code of AJANTPHARM.
Its Registered office is at "Ajanta House", Charkop,,Kandivli (West) Mumbai,Maharashtra - 400067.
Their Registrars are Link Intime India Pvt. Ltd.